Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non Hodgkin's lymphoma (NHL) in first complete remission (CR): A study of 542 patients (LNH87-2 protocol).

被引：0
|
作者：
Haioun, C [1 ]
Lepage, E [1 ]
Gisselbrecht, C [1 ]
Coiffier, B [1 ]
Bosly, A [1 ]
Dupriez, B [1 ]
Nouvel, C [1 ]
Tilly, H [1 ]
Lederlin, P [1 ]
Biron, P [1 ]
Briere, J [1 ]
Gaulard, P [1 ]
Reves, F [1 ]
机构：
[1] HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1816 / 1816
页数：1
相关论文
共 50 条
  • [41] Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens - A Southwest Oncology Group trial
    Stiff, PJ
    Dahlberg, S
    Forman, SJ
    McCall, AR
    Horning, SJ
    Nademanee, AP
    Blume, KG
    Leblanc, M
    Fisher, RI
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 48 - 55
  • [42] Gemcitabine and Docetaxel Protocol as Intent to Autologous Bone Marrow Transplantation in Patients with Refractory and Relapsed Non-Hodgkin Lymphoma: Single Institutional Prospective Phase II Study
    Sakr, Doaa H.
    Fahmi, Maryan Waheeb
    Ebrahim, Mohamed A.
    El Khodary, Tawfik Ragab
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S260 - S260
  • [43] CYTOXAN (CTX) + TOTAL-BODY IRRADIATION (TBI) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADULT LYMPHOBLASTIC LYMPHOMA (LBLL) IN 1ST COMPLETE REMISSION (CR) - A REPORT OF THE NON-HD-LYMPHOMA COOPERATIVE STUDY-GROUP, ITALY
    COSER, P
    SANTINI, G
    RIZZOLI, V
    CHISESI, T
    SERTOLI, R
    PORCELLINI, A
    CONTU, A
    CONGIU, M
    ROSSI, E
    MARMONT, A
    BLUT, 1987, 55 (04): : 247 - 247
  • [44] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma:: results of a multicenter phase II study
    Josting, A
    Sieniawski, M
    Glossmann, JP
    Staak, O
    Nogova, L
    Peters, N
    Mapara, M
    Dörken, B
    Ko, Y
    Metzner, B
    Kisro, J
    Diehl, V
    Engertl, A
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1359 - 1365
  • [45] Early autologous stem cell transplantation versus conventional first-line chemotherapy in high-risk aggressive non-Hodgkin's lymphomas (NHL): An Italian multicenter randomized trial.
    Gherlinzoni, F
    BLOOD, 1998, 92 (10) : 726A - 726A
  • [46] Autologous hematopoietic stem cell transplantation in elderly patients (≥70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study
    Hermet, E.
    Cabrespine, A.
    Guieze, R.
    Garnier, A.
    Tempescul, A.
    Lenain, P.
    Bouabdallah, R.
    Vilque, J. P.
    Frayfer, J.
    Bordessoule, D.
    Sibon, D.
    Janvier, M.
    Caillot, D.
    Biron, P.
    Legros, L.
    Choufi, B.
    Drenou, B.
    Gorin, N. C.
    Bilger, K.
    Tamburini, J.
    Soussain, C.
    Brechignac, S.
    Bay, J. O.
    JOURNAL OF GERIATRIC ONCOLOGY, 2015, 6 (05) : 346 - 352
  • [47] VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group
    Santini, G
    Salvagno, L
    Leoni, P
    Chisesi, T
    De Souza, C
    Sertoli, MR
    Rubagotti, A
    Congiu, AM
    Centurioni, R
    Olivieri, A
    Tedeschi, L
    Vespignani, M
    Nati, S
    Soracco, M
    Porcellini, A
    Contu, A
    Guarnaccia, C
    Pescosta, N
    Majolino, I
    Spriano, M
    Vimercati, R
    Rossi, E
    Zambaldi, G
    Mangoni, L
    Endrizzi, L
    Sileni, VC
    Miggiano, MC
    Marino, G
    Damasio, E
    Rizzoli, V
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2796 - 2802
  • [48] Early autologous stem cell transplantation (ASCT) versus conventional first-line chemotherapy in high-risk aggressive non-Hodgkin's lymphomas (NHL): An Italian Multicenter randomized trial.
    Gherlinzoni, F
    Martelli, M
    Tura, S
    BLOOD, 2000, 96 (11) : 481A - 481A
  • [49] Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis
    Koh, Yin Jie
    Girard, Louis-Pierre
    Chan, Hian Li Esther Hian Li
    Lee, Joanne Shu Xian
    Chee, Yen-Lin
    Jeyasekharan, Anand
    de Mel, Sanjay
    Soekojo, Cinnie Yentia
    Liu, Xin
    Koh, Liang Piu
    Poon, Michelle
    Samuel, Miny
    BLOOD, 2020, 136
  • [50] THROMBOPOIETIC EFFECT OF INTERLEUKIN-3 (IL-3) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH NON-HODGKIN-LYMPHOMA (NHL) OR HODGKINS-DISEASE (HD) - RESULTS FROM A PHASE-III PLACEBO-CONTROLLED STUDY
    FIBBE, WE
    VELLENGA, E
    BEZWODA, WR
    MARANINCHI, D
    HERMANN, R
    DURANT, S
    MARTELLI, M
    PICO, I
    SKLENAR, I
    GIANELLABORRADORI, A
    BLOOD, 1994, 84 (10) : A92 - A92
12345